Cheng Zhang, Shuqian Jing.  Therapeutic Antibody Approach for

Pulmonary Arterial Hypertension.  International Journal of Cardiology Research 1 (2021) 15–19.

Cheng Zhang, et al. Therapeutic Monoclonal Antibody Antagonizing Endothelin Receptor A for Pulmonary Arterial Hypertension. The Journal of Pharmacology and Experimental Therapeutics 370 (2019) 54–61.

Getagozumab: A Therapeutic Monoclonal Antibody Targeting Endothelin Receptor A for Pulmonary Arterial Hypertension
Poster number: 1013

A phase 1b/2a study of Glutazumab for the treatment of type 2 diabetes and obesity
Abstract number: 2298-PUB

Caina Li, et al. Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites. Biochemical Pharmacology 150 (2018) 46-53.

A phase I study to investigate the safety, tolerability and pharmacokinetics of a biased GLP-1R antibody Glutazumab

Abstract number: AD-1719

Poster number: P-0352